Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Inhibitors of voltage-gated potassium channels in the ICAgen pipeline

Oct. 7, 2002

Pharmacokinetic data reported for extended-release lovastatin

Oct. 7, 2002

Antiarrhythmic series covered by AstraZeneca patent

Oct. 4, 2002

Cardioprotective effects of JTV-519 and relationship to nitric oxide synthase

Oct. 4, 2002

Enrollment completed in DIAMOND and SILVER ALT-711 trials

Oct. 2, 2002

New inhibitors of malonyl-CoA decarboxylase and their use in heart failure, diabetes, obesity, etc.

Oct. 2, 2002

Marketing approval granted for first aldosterone blocker in high blood pressure

Oct. 1, 2002

Final phase I results for Antrin phototherapy in coronary artery disease

Oct. 1, 2002

ETC-642 evaluated in second phase I trial

Sep. 26, 2002

Inclusion of superiority data in Atacand labeling approved

Sep. 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...